Biomarkers in lung cancer
- PMID: 20515780
- DOI: 10.2741/e168
Biomarkers in lung cancer
Abstract
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
Similar articles
-
Prognostic and diagnostic usefulness of serum markers in lung cancer.Eur J Cancer Clin Oncol. 1987 Jul;23(7):893-4. doi: 10.1016/0277-5379(87)90330-0. Eur J Cancer Clin Oncol. 1987. PMID: 2822425 No abstract available.
-
Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.Eur J Cancer. 1994;30A(5):574-6. doi: 10.1016/0959-8049(94)90519-3. Eur J Cancer. 1994. PMID: 8080666 Review. No abstract available.
-
[The prescription of serum tumor markers in a general hospital].Presse Med. 1998 May 16;27(18):862, 864. Presse Med. 1998. PMID: 9767874 French. No abstract available.
-
Elastase levels in small and non-small cell lung carcinoma.Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):305S. doi: 10.1042/bst021305s. Biochem Soc Trans. 1993. PMID: 8224451 No abstract available.
-
Serum tumour markers in lung cancer.Scand J Clin Lab Invest Suppl. 1991;206:93-101. doi: 10.3109/00365519109107730. Scand J Clin Lab Invest Suppl. 1991. PMID: 1658919 Review. No abstract available.
Cited by
-
The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.Int J Clin Oncol. 2011 Dec;16(6):679-85. doi: 10.1007/s10147-011-0248-9. Epub 2011 May 11. Int J Clin Oncol. 2011. PMID: 21556796
-
Lung Cancer: New Directions in Senior Patients Assessment.Geriatrics (Basel). 2024 Aug 1;9(4):101. doi: 10.3390/geriatrics9040101. Geriatrics (Basel). 2024. PMID: 39195131 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous